Systematic analysis of microorganisms’ metabolism for selective targeting

Author:

Manshadi Mehdi Dehghan,Setoodeh Payam,Zare HabilORCID

Abstract

AbstractSelective drug targets (i.e., narrow-spectrum antibiotics) can minimize side effects of antibiotic treatments compared to broad-spectrum antibiotics due to their specific targeting of the organisms responsible for the infection. Furthermore, combating an infectious pathogen, especially a drug-resistant organism, is more efficient by attacking multiple targets. Here, we combined synthetic lethality with selective drug targeting to obtain multi-target and organism-specific potential drug candidates by systematically analyzing the genome-scale metabolic models of six different microorganisms. By considering microorganisms as targeted or conserved in one- to six-member groups, we designed 665 individual case studies. For each case, we identified single essential reactions as well as double, triple, and quadruple synthetic lethal reaction sets that are lethal for targeted microorganisms and neutral for conserved ones. As expected, the number of obtained solutions for each case depends on the genomic similarity between the studied microorganisms. Mapping the identified potential drug targets to their corresponding pathways showed the importance of key subsystems such as cell envelope biosynthesis, glycerophospholipid metabolism, membrane lipid metabolism, and the nucleotide salvage pathway. To assist validation and further investigation of our proposed potential drug targets, we introduced two sets of targets that can potentially address a substantial portion of the 665 cases. We expect that the obtained solutions provide helpful insights into designing narrow-spectrum drugs that selectively cause system-wide damage only to the target microorganisms.

Publisher

Cold Spring Harbor Laboratory

Reference64 articles.

1. Microbiome and infection: a case for “selective depletion”;Annals of Nutrition and Metabolism,2021

2. Connecting the dots: Targeting the microbiome in drug toxicity;Medicinal Research Reviews,2022

3. the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease;Alimentary pharmacology & therapeutics,2018

4. Microbiome as a therapeutic target in alcohol-related liver disease;Journal of hepatology,2019

5. The brain-gut-microbiome axis;Cellular and molecular gastroenterology and hepatology,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3